We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Topical Immunotherapy Lowers Risk of Skin Cancer

News   Mar 22, 2019 | Original story from Washington University School of Medicine in St. Louis

 
Topical Immunotherapy Lowers Risk of Skin Cancer

Washington University dermatologist Lynn Cornelius, MD, (left) conducts a skin exam with patient Robert Manchester. Manchester was a participant in a clinical trial testing the effectiveness of a topical immunotherapy against precancerous skin lesions called actinic keratoses, often found on sun-damaged skin. A three-year follow-up analysis suggests the therapy also reduces the risk that the precancerous lesions will progress to skin cancer. Credit: Washington University

 
 
 

RELATED ARTICLES

Testing Personalized Treatments in 5 days With 3D

News

Researchers have developed a cell co-culture platform that can reproduce a patient’s tumor in 3D and test the best treatment combinations for its specific case in just five days.

READ MORE

New Opioid Accelerates Recovery Time From Pain Compared to Morphine, Preclinical Study Shows

News

A new type of opioid doesn’t have the side effects (such as increased pain sensitivity or and increased risk of chronic pain) associated with morphine and other opioid-based painkillers, and accelerates recovery time from pain compared to morphine, according to a new preclinical study.

READ MORE

Molecular Escorts Keep Cancer in Check

News

A new study by Technical University of Munich (TUM) researchers uncovers the role of special proteins, known as chaperones, in the regulation of cellular machinery in cancer cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE